$143M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | PRAX Praxis Precision Medicines I | 82,796 | −2.5% | $28M | 19.3% |
| 2 | WHWK Whitehawk Therapeutics Inc | 4.7M | +37.4% | $21M | 15.0% |
| 3 | TNGX Tango Therapeutics Inc | 390,949 | −11.5% | $12M | 8.5% |
| 4 | STRO Sutro Biopharma Inc | 270,251 | +0.3% | $9M | 6.3% |
| 5 | AVBP Arrivent Biopharma Inc | 218,694 | — | $8M | 5.3% |
| 6 | FDMT 4D Molecular Therapeutics In | 507,801 | — | $7M | 4.7% |
| 7 | DRUG Bright Minds Biosciences Inc | 92,745 | −17.2% | $7M | 4.5% |
| 8 | OCUL Ocular Therapeutix Inc | 532,481 | −10.1% | $5M | 3.6% |
| 9 | ERAS Erasca Inc | 265,199 | −25.2% | $5M | 3.4% |
| 10 | SRZN Surrozen Inc | 173,395 | +0.3% | $4M | 3.1% |
| 11 | ARGX Argenx Se | 4,705 | +0.3% | $4M | 3.0% |
| 12 | MLTX Moonlake Immunotherapeutics | 215,652 | +12.5% | $4M | 2.9% |
| 13 | DSGN Design Therapeutics Inc | 282,564 | +93.7% | $4M | 2.8% |
| 14 | NERV Minerva Neurosciences Inc | 709,500 | +0.0% | $4M | 2.7% |
| 15 | TSHA Taysha Gene Therapies Inc | 561,808 | +27.8% | $4M | 2.7% |
| 16 | AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc | 115,000 | — | $4M | 2.6% |
| 17 | AVTX Avalo Therapeutics Inc | 186,308 | +206.4% | $3M | 2.4% |
| 18 | AMLX Amylyx Pharmaceuticals Inc | 168,115 | +11.3% | $3M | 2.1% |
| 19 | ARTV Artiva Biotherapeutics Inc | 260,416 | — | $3M | 1.8% |
| 20 | CMPX Compass Therapeutics Inc | 595,213 | −29.9% | $1M | 0.9% |
| 21 | UTHR United Therapeutics Corp Del | 2,224 | +0.0% | $1M | 0.8% |
| 22 | CTNM Contineum Therapeutics Inc | 63,095 | — | $1M | 0.7% |
| 23 | LBRX Lb Pharmaceuticals Inc | 28,919 | +0.0% | $938,566 | 0.7% |